Market Place
Sourcing Support
Outcome Capital Announces Acquisition of Propella Therapeutics
04 Jan 2024 //
BUSINESSWIRE
Astellas completes acquisition of Propella Therapeutics
26 Dec 2023 //
INDIAN PHARMA POST
Astellas to Acquire Propella Therapeutics
15 Nov 2023 //
PR NEWSWIRE
Propella Announces Presentation of Ph1/2a Data of PRL-02 for Prostate Cancer
14 Feb 2023 //
GLOBENEWSWIRE
Propella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02
08 Sep 2022 //
GLOBENEWSWIRE
Propella Tx Signs Licensing Agreement with Jiangsu Aosaikang Pharmaceutical
07 Apr 2022 //
GLOBENEWSWIRE
Propella Announces First Patient Dosed in Phase 1/2a Trial of PRL-02
29 Jun 2021 //
GLOBENEWSWIRE
Propella Therapeutics Receives FDA Clearance to Begin Phase 1 Clinical Study
18 May 2021 //
PRNEWSWIRE
Propella Therapeutics Partners with National Cancer Institute to Develop New
23 Feb 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.